Fertility Supplement Market Expected to Reach $3,652.50 Million by 2030

According to a new report published by Allied Market Research, titled, “Fertility Supplement Market by Ingredient, Product, End User, and Region: Global Opportunity Analysis and Industry Forecast, 2021–2030," The global fertility supplement market size generated $1,754.00 million in 2020 and is projected to reach $3,652.50 million by 2030, growing at a CAGR of 7.50% from 2021 to 2030.

Fertility supplements are the supplements that are consumed by individuals to improve their fertility rate. In other words, it is a kind of natural process that helps individuals in reproducing their off-springs.

Rising infertility rate and surge in the number of fertility clinics are the major factors fostering the growth of the market. Furthermore, changing lifestyle, growing technological advancements in the field of healthcare and rising introduction of innovative products are other important factors acting as market growth determinants. Growing consumption of alcohol and tobacco products and developing tastes and preferences of consumers for caffeine oriented products will further induce growth in the market value.

However, lack of dosing flexibility and difficulty to swallow owing to large sized pills will pose a major challenge to the growth of the market. Lack of awareness and knowledge in the underdeveloped economies will also hamper the market growth rate.

The sudden outbreak of the COVID-19 has brought the whole world to a standstill. As hospitals are getting filled with COVID-19 positive patients, the burden on healthcare staff is increasing. In addition, the postponement and cancellation of fertility appointments have decreased patient volume in hospitals and clinics and create a negative impact on the market.

In the last 50 years, the sperm concentration has fallen by 52% among men in Western countries. Four decades ago, the average Western man had a sperm concentration of 99 million per milliliter. By 2018, that had fallen to 47.1 million according to the Hebrew University public health research. The plummet is alarming because sperm concentration below 40 million per milliliter is considered below normal and can impair fertility. All these factors have resulted in an increasing demand for fertility supplements for men.

According to the National Survey of Family Growth, the percentage of married women aged 15 to 44 years who are infertile has remained relatively stable since 2010. However, among married infertile women aged 40 to 44 years had the greatest prevalence of fertility issues, followed by women aged 35 to 39. Initiatives by government and nonprofit organizations to provide advice and medical help has helped bring awareness resulting in creating opportunities for the product manufacturers in the market.

The fertility supplement market is driven by increase in infertility rates, rise in trend of delayed pregnancies, and growth in disposable income. Furthermore, rise in prevalence of infertility due to increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities for the market growth during the forecast period.

By ingredient, the natural segment accounted for more than half of the market share in fertility supplement market in 2020. This segment is expected to exhibit a prominent growth rate, owing to, introduction of innovative products and technological advancements in health and wellness industry are anticipated to boost the growth of natural fertility supplement segment over the forecast period. Increasing utilization of plant-derived products for a healthy lifestyle and to reduce the risk of side effects is expected to further propel the demand in the near future.

By product, the capsules segment accounted for major share of the market share in fertility supplements market in 2020. These products enable unique mixes of ingredients, provide protection from sensitive ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery. This factor is anticipated to boost the segment growth.

By end user, the women segment accounted for major share of the market share in fertility supplement market in 2020. This segment is expected to exhibit a considerable growth rate. Immune system factors, hypogonadism, varicocele, systemic disease, sexual factors, urogenital infection are some of the prominent factors leading to fertility problems in women.

Europe was the largest shareholder in the global fertility supplement market in 2020, due to the high awareness of fertility supplements and Initiatives adopted by various authorities to educate people about the benefits of fertility supplements are driving the market in Europe. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to development in the healthcare infrastructure, and rise in fertility tourism. In addition, rising awareness in China and India regarding nutritional enrichment is expected to remain a favorable factor for regional growth. Furthermore, expansion in retail market in emerging markets including China, Indonesia, Malaysia, and India in light of regulatory support to promote investments is expected to increase the accessibility to buyers over the forecast period.

The key players operating in the global fertility supplement market include Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc.,PregPrep LLC, Bionova, TTK HealthCare Ltd.,Fertility Nutraceuticals LLC.

Key Findings Of The Study

• By ingredient, the natural segment held 35.59% share in the global fertility supplement market in 2020.
• By product, the capsule segment exhibit fastest growth and is expected to grow at a CAGR of 8.20% from 2021 to 2030.
• By end user, the women segment held largest market share in 2020 and is expected to remain dominant throughout the forecast period.
• By region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.10% during the forecast period.